Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro
Progress in brain research (2019), pp. 91-129
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Diverse Molecular Mechanisms Underlying Pathogenic Protein Mutations: Beyond the Loss-of-Function Paradigm
Lisa Backwell, Joseph A. Marsh
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 475-498
Open Access | Times Cited: 83
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s Disease
Tahereh Sohrabi, Behnaz Mirzaei-Behbahani, Ramin Zadali, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 167992-167992
Open Access | Times Cited: 43
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 18
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Inês Caldeira Brás, Tiago F. Outeiro
Cells (2021) Vol. 10, Iss. 2, pp. 375-375
Open Access | Times Cited: 92
Autophagy in Parkinson’s Disease
Lior Nechushtai, Dan Frenkel, Ronit Pinkas‐Kramarski
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1435-1435
Open Access | Times Cited: 32
Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
Andrea Becerra-Calixto, Abhisek Mukherjee, Santiago Ramírez, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 625-625
Open Access | Times Cited: 25
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Antonio Dominguez‐Meijide, Valeria Parrales, Eftychia Vasili, et al.
Neurobiology of Disease (2021) Vol. 151, pp. 105256-105256
Open Access | Times Cited: 55
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Antonella Cardinale, Valeria Calabrese, Antonio de Iure, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6517-6517
Open Access | Times Cited: 53
Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
Marie‐Therese Mackmull, Luise Nagel, Fabian Sesterhenn, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 978-989
Closed Access | Times Cited: 34
N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates
Rosie Bell, Rebecca J. Thrush, Marta Castellana-Cruz, et al.
Biochemistry (2022) Vol. 61, Iss. 17, pp. 1743-1756
Open Access | Times Cited: 32
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD
Michiyo Iba, Changyoun Kim, Somin Kwon, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 21
Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease
Elizabeth Riegelman, Kathy S. Xue, Jia-Sheng Wang, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2041-2041
Open Access | Times Cited: 7
Revisiting Alpha-Synuclein Pathways to Inflammation
Patrícia Lyra, Vanessa Machado, Silvia Rota, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7137-7137
Open Access | Times Cited: 16
Mitochondria and Antibiotics: For Good or for Evil?
Juan M. Suárez-Rivero, Carmen J. Pastor‐Maldonado, Suleva Povea-Cabello, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1050-1050
Open Access | Times Cited: 31
All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species
Aitor Franco, Pablo Gracia, Adai Colom, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 36
Open Access | Times Cited: 28
Extracellular alpha-synuclein: Sensors, receptors, and responses
Renato Domingues, Ricardo Sant’Anna, Anna Carolina Carvalho da Fonseca, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105696-105696
Open Access | Times Cited: 21
Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
Alcmène Chalazonitis, Meenakshi Rao, David Sulzer
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 20
A novel alpha-synuclein K58N missense variant in a patient with Parkinson's disease
Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advances in autophagy for Parkinson’s disease pathogenesis and treatment
Xiaojie Zhang, Huan Zhang, Jie Dong, et al.
Ageing and Neurodegenerative Diseases (2025) Vol. 5, Iss. 1
Open Access
A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies
David J. Koss, Olivia Todd, Hariharan Menon, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Hypothermia Shifts Neurodegeneration Phenotype in Neonatal Human Hypoxic–Ischemic Encephalopathy but Not in Related Piglet Models: Possible Relationship to Toxic Conformer and Intrinsically Disordered Prion-like Protein Accumulation
Lee J. Martin, Jennifer K. Lee, Mark V. Niedzwiecki, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 586-586
Open Access
Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned
Albert Y. Hung, Michael A. Schwarzschild
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1393-1405
Open Access | Times Cited: 30
The interplay between neuroinflammatory pathways and Parkinson's disease
Pınar Eser Ocak, Ersoy Kocabıçak, Ahmet Bekâr, et al.
Experimental Neurology (2023) Vol. 372, pp. 114644-114644
Open Access | Times Cited: 10
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo
Tobias Thom, Matthias Schmitz, Anna‐Lisa Fischer, et al.
Movement Disorders (2021) Vol. 37, Iss. 1, pp. 39-51
Open Access | Times Cited: 18
Synuclein in neurodegeneration
Anastasia Bougea
Advances in clinical chemistry (2020), pp. 97-134
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top